It has the effects of anti-platelet aggregation, dilating arterioles, improving microcirculation, activating blood circulation and removing blood stasis, and has the effect of disaggregating aggregated platelets

Prevent nitrogen loss, correct negative nitrogen balance and reduce protein consumption

Prevent nitrogen loss, correct negative nitrogen balance and reduce protein consumption

Prevent nitrogen loss, correct negative nitrogen balance and reduce protein consumption

Prevent nitrogen loss, correct negative nitrogen balance and reduce protein consumption

This product is a broad-spectrum antibacterial agent, with bactericidal effect at high concentrations. It has certain antibacterial effects on Streptococcus pneumoniae, hemolytic Streptococcus, Streptococcus viridans and some Staphylococci, Clostridium perfringens, Bacillus anthracis, Yersinia pestis, Corynebacterium diphtheriae, Clostridium tetani, Brucella, Haemophilus influenzae, Campylobacter, Vibrio cholerae, and also has inhibitory effects on Rickettsia, Mycoplasma, Chlamydia, Spirochete, and some protozoa. It has better effects on Gram-positive bacteria than Gram-negative bacteria, but Enterococcus is resistant to it. Others such as Actinomyces, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, etc. are also sensitive to this product. It has certain antibacterial activity against Neisseria gonorrhoeae and Neisseria meningitidis, but penicillin-resistant gonococci are also resistant to tetracycline. It has no antibacterial activity against Pseudomonas aeruginosa. It has a certain antibacterial effect on some anaerobic bacteria, but it is far less effective than metronidazole, clindamycin and chloramphenicol, so it is not used clinically. Due to the widespread use of tetracyclines for many years, common clinical pathogens, including Gram-positive bacteria such as Staphylococcus and Gram-negative bacteria such as Enterobacter, are seriously resistant to tetracycline, and there is cross-resistance between similar varieties. The mechanism of action of this product is that the drug can specifically bind to the A position of the 30S subunit of the bacterial ribosome, preventing the binding of aminoacyl-tRNA at this position, thereby inhibiting the growth of peptide linkages and affecting the synthesis of bacterial proteins.